Celon Pharma SA Cash Flow Reinvestment Rate
Celon Pharma SA cash flow reinvestment rate. Celon Pharma SA (CLN) has a Cash Flow Reinvestment Rate of 0.72x as of December 2025, reinvesting zł26.48 Million (capex zł26.48 Million ) from operating cash flow of zł36.63 Million. See CLN financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Celon Pharma SA (2012–2025)
Cash flow reinvestment rate of Celon Pharma SA from 2012 to 2025. Historical reinvestment intensity for Celon Pharma SA across 10 annual periods. Explore CLN debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Celon Pharma SA Cash Flow Reinvestment Rate by Year (2012–2025)
Celon Pharma SA cash flow reinvestment rate by year from 2012 to 2025. Year-by-year capital reinvestment analysis for Celon Pharma SA. For the full cash flow conversion analysis, see Celon Pharma SA cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.28x | zł54.44 Million | zł23.86 Million | zł54.44 Million | ▼ -17.3% |
| 2021 | 2.76x | zł121.22 Million | zł43.95 Million | zł41.35 Million | ▲ +35.2% |
| 2020 | 2.04x | zł144.60 Million | zł70.90 Million | zł99.16 Million | ▼ -14.6% |
| 2018 | 2.39x | zł67.47 Million | zł28.24 Million | zł67.46 Million | ▲ +92.8% |
| 2017 | 1.24x | zł31.35 Million | zł25.30 Million | zł31.34 Million | ▲ +20.2% |
| 2016 | 1.03x | zł21.29 Million | zł20.65 Million | zł21.29 Million | ▲ +20.4% |
| 2015 | 0.86x | zł44.86 Million | zł52.37 Million | zł44.86 Million | ▼ -7.5% |
| 2014 | 0.93x | zł22.55 Million | zł24.36 Million | zł22.55 Million | ▲ +38.6% |
| 2013 | 0.67x | zł5.64 Million | zł8.45 Million | zł5.64 Million | ▲ +97.8% |
| 2012 | 0.34x | zł4.34 Million | zł12.87 Million | zł4.34 Million | — |